PRESENTATIONS

PIPELINE PRESENTATIONS

Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Targeted Radiopharmaceuticals Summit US (TRP) – Boston, Massachusetts
July 25, 2023

Fibroblast Activation Protein (FAP)- a target for Imaging and Therapy

FAP Ligands for Imaging and Therapy

Sponsored by SOFIE
Satellite Symposium, 2023 Annual SNMMI Meeting – Chicago, IL
June 25, 2023

SOFIE FAPI diagnostic-clinical development updates

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2023 Annual SNMMI Meeting – Chicago, Illinois
June 25, 2023

FAPI diagnostic- clinical development updates

Webinar: Current State of FAP Ligands for Diagnostic Use in Oncology

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 14, 2023

FAPI Oncology

FAPI Theragnostics

Presented by: Prof. Dr. Frederik L. Giesel, MD, MBA; Chair of Nuclear Medicine, Department of Nuclear Medicine; University Hospital Düsseldorf, Germany
World Theragnostics Day – Focus on FAPI
March 31, 2023

Fibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology, Fibrotic Disease, and Cardiovascular Disease

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Informa Connect: Radiopharmaceuticals and Imaging Digital Conference
March 14, 2023

FAPI Clinical Development Updates

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
ICPO Theranostics FAP Summit (virtual)
November 5, 2022

ICPO Presentation

Current Status of Clinical Trials on FAP Targeted Radiopharmaceuticals

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Gordon Research Conference-Radionuclide Theranostics for the Management of Cancer – Newry, Maine
July 19, 2022

FAP Current State

FAP Ligands for Imaging and Therapy

SOFIE/Clovis Oncology/POINT Biopharma
Satellite Symposium, 2022 Annual SNMMI Meeting – Vancouver Canada
June 12, 2022

FAP Ligands for Imaging and Therapy

FAP-Ligand PET Update ≠ Cancer

Presented by: Professor Jeremie Calais, MD, MSc, Professor, University of California, Los Angeles
2022 Annual SNMMI Meeting – Vancouver, Canada
June 12, 2022

FDG Uptake

SOFIE FAPI Clinical Development Update

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2022 Annual SNMMI Meeting – Vancouver, Canada
June 12, 2022

Webinar: Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 8, 2022

2019 SNMMI Image of the Year

Presented by: Professor Frederik L. Giesel, MD, MBA, University Hospital Düsseldorf, Germany
2019 Annual SNMMI Meeting – Anaheim, CA
June 25, 2019

CONTACT US

Are you a pharmaceutical company or distribution network interested obtaining FAPI for your projects and patients? We are eager to learn more about how our compounds can facilitate your needs.